EVALUATED EFFECTS OF THE TREATMENT WITH IMATINIB OF CHRONIC MYELOID LEUKEMIA PATIENTS WITH ADDITIONAL CYTOGENETIC ABNORMALITIES IN HEMATOLOGY AND BLOOD TRANSFUTION CENTER, BACHMAI HOSPITAL. YHCĐ. 2026;67(2). doi:10.52163/yhc.v67i2.4337